Literature DB >> 2166380

Investigation of focal hepatic lesions: is tomographic red blood cell imaging useful?

D C Farlow1, P R Chapman, S M Gruenewald, V F Antico, G C Farrell, J M Little.   

Abstract

Noninvasive diagnosis of cavernous hemangioma of the liver is an important step in the investigation of patients with focal hepatic lesions since biopsy may result in life-threatening hemorrhage. To determine the diagnostic accuracy of 99m-technetium red blood cell (99mTc-RBC) imaging with tomography, 50 patients with various types of focal liver lesions were studied. Thirty-two patients had 45 hemangiomas and 7 other benign lesions while 18 patients had either primary (n = 8) or secondary (n = 10) hepatic malignancies. Tomographic imaging identified 12 more hemangiomas than planar imaging, improving sensitivity from 53% to 80%, and was found most useful for detection of smaller lesions (mean size, 2.1 cm). Specificity for hemangiomas was 100% with all lesions greater than 1.9 cm showing the characteristic scintigraphic pattern of blood-pooling on delayed images. There was excellent agreement between 2 independent observers concerning interpretation of tomographic images (89% for the hemangioma group and 100% for other patients). Therefore 99mTc-RBC scintigraphy with tomography is an accurate diagnostic technique in the investigation of cavernous hemangiomas. Its major value resides in its ability to distinguish hemangiomas from other types of hepatic pathology.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166380     DOI: 10.1007/BF01658668

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  17 in total

1.  Benign tumors of the liver.

Authors:  K G Ishak; L Rabin
Journal:  Med Clin North Am       Date:  1975-07       Impact factor: 5.456

2.  A modified method for the in vivo labeling of red blood cells with Tc-99m: concise communication.

Authors:  R J Callahan; J W Froelich; K A McKusick; J Leppo; H W Strauss
Journal:  J Nucl Med       Date:  1982-04       Impact factor: 10.057

3.  Solitary echogenic spot in the liver: is it diagnostic of a hemangioma?

Authors:  R L Bree; R E Schwab; H L Neiman
Journal:  AJR Am J Roentgenol       Date:  1983-01       Impact factor: 3.959

4.  Computed tomography and angiography of cavernous hemangiomas of the liver.

Authors:  C M Johnson; P F Sheedy; A W Stanson; D H Stephens; R R Hattery; M A Adson
Journal:  Radiology       Date:  1981-01       Impact factor: 11.105

5.  Cavernous hemangioma of the liver: detection with single-photon emission computed tomography.

Authors:  S S Tumeh; C Benson; J S Nagel; R J English; B L Holman
Journal:  Radiology       Date:  1987-08       Impact factor: 11.105

6.  99mTc red blood cell scintigraphy in evaluating focal liver lesions.

Authors:  S A Rabinowitz; K A McKusick; H W Strauss
Journal:  AJR Am J Roentgenol       Date:  1984-07       Impact factor: 3.959

7.  Hepatic angiosarcoma: mimicking of angioma on three-phase technetium-99m red blood cell scintigraphy.

Authors:  F Ginsberg; J D Slavin; R P Spencer
Journal:  J Nucl Med       Date:  1986-12       Impact factor: 10.057

8.  Differentiation of focal intrahepatic lesions with 99mTc-red blood cell imaging.

Authors:  M A Engel; D S Marks; M A Sandler; P Shetty
Journal:  Radiology       Date:  1983-03       Impact factor: 11.105

9.  Noninvasive diagnosis of small cavernous hemangioma of the liver: advantage of MRI.

Authors:  Y Itai; K Ohtomo; S Furui; T Yamauchi; M Minami; N Yashiro
Journal:  AJR Am J Roentgenol       Date:  1985-12       Impact factor: 3.959

10.  Hepatic cavernous hemangioma: diagnosis with 99mTc-labeled red cells and single-photon emission CT.

Authors:  R I Brodsky; A C Friedman; A H Maurer; P D Radecki; D F Caroline
Journal:  AJR Am J Roentgenol       Date:  1987-01       Impact factor: 3.959

View more
  1 in total

1.  Hepatic incidentaloma: a modern problem.

Authors:  J M Little; J Kenny; M J Hollands
Journal:  World J Surg       Date:  1990 Jul-Aug       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.